Trial ChiCTR2000029765
Publication Wang D, Lancet (pre-print), 2020
Primary outcome on the report: Cure rate of the enrolled patients (defined as 1)fever attenuated for continuously 7 days, 2) twice COVD-19 nucleolus acid detections negative, 3) CT scan shows chest effusion absorbed more than 50% percent when the patient is discharged from hospital)